Related Experiment Video
Updated: Sep 15, 2025

Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases
Published on: October 10, 2020
β-Glucuronidase Acts as a Novel Nonantioxidative Target for Vitamin E
Wenjing Li1, Ling Xiao2, Juan Qi1
1Innovation Center of Targeted Development of Medicinal Resources (iCTM), Anqing Normal University, 1318 Jixianbei Road, Anqing 246311, China.
None:
Inhibition of gut β-glucuronidase (GUS) protects the gastrointestinal tract by reducing local exposure to toxic aglycones from inactive glucuronides. Development of highly safe GUS inhibitors has attracted extensive attentions. The current study demonstrates that natural and synthetic vitamin E (VE) analogues all display potent inhibition toward GUS. dl-α-tocopherol acts as the most potent inhibitor with the Ki value of 0.14 μM, while the other analogues have Ki values below 15.1 μM. Docking analysis indicates that the amino residues in the active pocket of GUS form various hydrophobic interactions with both the chromanol ring and side chain of VE, as well as hydrogen bonds with the hydroxyl group. It is predicted that GUS inhibition readily occurs owing to the daily intake of common plant foods. The current study offers highly safe inhibitors for GUS, as well demonstrates a novel nonantioxidant target for VE providing new insights into the vitamin's gastrointestinal protection.
More Related Videos
Related Concept Videos
Phase II Reactions: Glucuronidation
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Radical Autoxidation

